Get the Stockscreener App
274.50
0.19%
-0.8939
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $274.50, with a volume of 1.02M.
It is down -0.19% in the last 24 hours and down -20.51% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$275.39
Open:
$274.62
24h Volume:
1.02M
Relative Volume:
0.41
Market Cap:
$105.34B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
31.79
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
-10.75%
1M Performance:
-20.51%
6M Performance:
-23.36%
1Y Performance:
-28.22%
1-Day Range:
$270.89
$278.00
1-Week Range:
$270.85
$307.55
52-Week Range:
$270.85
$392.55
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
274.63 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
104.35 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.61 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
43.98 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.52 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker Corporation $SYK Shares Acquired by Tidal Investments LLC - MarketBeat
WINTON GROUP Ltd Grows Position in Stryker Corporation $SYK - MarketBeat
NJ Electrical Manufacturer Taps Longtime Stryker Atty As GC - Law360
BMO cuts Stryker stock price target on revised estimates to $317 - Investing.com Nigeria
Stryker To Acquire ZuriMED To Expand Shoulder And Rotator Cuff Portfolio - Pulse 2.0
Stryker acquires Swiss firm to expand shoulder repair business - Crain's Grand Rapids
Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating - marketscreener.com
Is Stryker (NYSE:SYK) a stock worth watching as trading resumes? - Kalkine Media
Wells Fargo cuts Stryker stock price target on revenue concerns By Investing.com - Investing.com India
Stryker Stock Drops Over 7% As Supply Chain Constraints Impact Peripheral Vascular Business - TIKR.com
Duke Health, Stryker put augmented reality to work in hip surgery - Modern Healthcare
Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating - marketscreener.com
BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating - marketscreener.com
Stryker (NYSE:SYK) Sets New 12-Month LowShould You Sell? - MarketBeat
A 6-Day Losing Streak Has Stryker Stock Down 16% - Trefis
Baird Financial Group Inc. Sells 5,319 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Stock Declines as Manufacturing Issues Continue - Moomoo
United StatesMintz Advises ZuriMED Shareholders In Acquisition By Stryker - Mondaq
533,784 Shares in Stryker Corporation $SYK Purchased by Veritas Asset Management LLP - marketbeat.com
Is Stryker Corp (SYK) a Bargain After 8.8% Drop? GF Value Says U - GuruFocus
Stryker Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
SYK ALERT: Stryker Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm - GlobeNewswire
Stryker (NYSE: SYK) VP, controller discloses 5,538 stock options - Stock Titan
Cyberattacks Hit Boston Scientific and Stryker, Clouding Outlooks - Briefs Finance
Supply chain woes send Stryker stock tumbling 7.7% - Investing.com
Stryker (NYSE:SYK) Shares Down 6.2%What's Next? - MarketBeat
Stryker at wells fargo healthcare conference: growth tested by supply - Investing.com Canada
Supply chain woes send Stryker stock tumbling 7.7% By Investing.com - Investing.com India
Boston Scientific Unlikely to Meet Forecasts After Cyber Attack - bloomberg.com
Why Stryker (SYK) Stock Is Down Today - Quiver Quantitative
Stryker stock drops after CFO remarks (SYK:NYSE) - Seeking Alpha
Stryker Corporation stock hits 52-week low at 280.99 USD - Investing.com
Stryker Corp. stock gains on stronger earnings and raised guidance - ad-hoc-news.de
Agilent Names Dow Wilson Board Chair, Adds Former Stryker CFO Glenn Boehnlein - citybiz
Stryker (SYK) Stock Could Be 28% Undervalued After A Shoulder Tech Deal - simplywall.st
Why Stryker (NYSE:SYK) Is in Focus After the NYSE Reopens? - Kalkine Media
Stryker Corporation $SYK Stock Position Lifted by Amundi - marketbeat.com
Stryker stock gains after a revenue beat and higher guidance - ad-hoc-news.de
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Zacks Investment Research
HighTower Advisors LLC Has $153.01 Million Stake in Stryker Corporation $SYK - marketbeat.com
Stryker Corporation (SYK) Stock Analysis: Exploring a 26% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews
Hsbc Holdings PLC Raises Stock Position in Stryker Corporation $SYK - marketbeat.com
Stryker Corporation $SYK Shares Purchased by California State Teachers Retirement System - marketbeat.com
Saudi Central Bank Has $7.60 Million Stock Position in Stryker Corporation $SYK - MarketBeat
Stryker Investors With Losses: Contact Block & Leviton LLP About Its Investigation and Potential Recovery Options - natlawreview.com
Apple Vision Pro enters hip surgery with Stryker’s FDA-authorized app - The Rundown AI
Oakmont Investment Advisors Inc. Takes Position in Stryker Corporation $SYK - marketbeat.com
Sapient Capital LLC Acquires 3,794 Shares of Stryker Corporation $SYK - MarketBeat
NEOS Investment Management LLC Increases Stock Position in Stryker Corporation $SYK - MarketBeat
Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference - marketscreener.com
More than 150 million patients are impacted annually by Stryker. Executives speak Sept. 8. - Stock Titan
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):